Playback speed×Share postShare post at current timeShare from 0:000:00/Paid episodeThe full episode is only available to paid subscribers of JNap’s Biotech ThoughtsSubscribe to watchReplimune - deja vu vu?RP1 BLA re-filing imminent for 3rd time try at approvalJNapMay 29, 2026∙ Paid1ShareHello Subs,Here are my thoughts on what REPL is worth right now (odds-adjusted) and what it could be worth if RP1 does get approved later this year.Cheers,JNapSubscribeContinue reading this post for free, courtesy of JNap.Claim my free postOr purchase a paid subscription.JNap PodcastSubstack for Remsen Investors LP, Bio5C, and anyone else interested in biopharma investing!Substack for Remsen Investors LP, Bio5C, and anyone else interested in biopharma investing!SubscribeListen onSubstack AppApple PodcastsSpotifyRSS FeedAppears in episodeJNapRecent EpisodesQuick Thoughts & Valuation on QURE20 hrs ago • JNapStock Q&A (Free)Jun 11 • JNapIsn't This Fun?Jun 3 • JNapFull Top Ideas ReviewMay 21 • JNapPreviewing Larimar's June UpdateMay 14 • JNapPharvaris (PHVS) - Two Blockbuster HAE AssetsMay 13 • JNapA Lotto Idea In IPF?May 4 • JNap